HopeStage
Back to all studies
RecruitingNCT06683014

MDMA in Borderline Personality Disorder

This study is recruiting. It focuses on personality disorders and currently lists participation information in the United States.

Personality disorders, Borderline personalityDrugFrom 18 Years to 60 Years
In plain English

Key information made simple

What is this study testing?

This study is testing whether MDMA may be useful for adults experiencing personality disorders.

What would participation involve?

Participants may receive MDMA, attend study visits with the research team. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with personality disorders.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: September 5, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
10
Sponsor
Yale University
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 60 Years
Official registry ID
NCT06683014
Official title
The Effects of MDMA (3,4-methylenedioxymethamphetamine) in Social Cognition in Borderline Personality Disorder

Want help reviewing this study?

Loading the security check...
Study ID: NCT06683014. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Recruiting

New Haven

Registry details
Registry conditions (original wording)

Borderline Personality Disorder

In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University.

Does this study involve medication?

The study includes MDMA.

Who can participate?

Listed age limits: 18 years to 60 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me